Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System by Seini Moimoi | Apr 19, 2022 | Portfolio News
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn by Seini Moimoi | Apr 13, 2022 | Portfolio News
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy by Seini Moimoi | Apr 7, 2022 | Portfolio News
IntelyCare Secures $115 Million Series C Financing Led by Janus Henderson Investors by Seini Moimoi | Apr 6, 2022 | Portfolio News
Axonics® Launches Direct to Consumer Television Advertising Campaign by Seini Moimoi | Apr 4, 2022 | Portfolio News
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer by Seini Moimoi | Mar 28, 2022 | Portfolio News
89bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update by Seini Moimoi | Mar 24, 2022 | Portfolio News
Aptinyx Reports Fourth Quarter and Full Year 2021 Results and Highlights by Seini Moimoi | Mar 23, 2022 | Portfolio News
Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights by Seini Moimoi | Mar 15, 2022 | Portfolio News
Dascena Awarded NIH Grant to Reduce Bias in Acute Coronary Syndrome Diagnosis and Treatment by Seini Moimoi | Mar 9, 2022 | Portfolio News
